These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 20373270
1. [Implementation of "aut idem" before and after introduction of rebate contracts]. Hoffmann F, Windt R, Glaeske G. Dtsch Med Wochenschr; 2010 Apr; 135(15):739-44. PubMed ID: 20373270 [Abstract] [Full Text] [Related]
2. [Regional differences in the use of 'no substitution' in the elderly after introduction of rebate contracts]. Hoffmann F, Windt R, Glaeske G. Gesundheitswesen; 2011 Jul; 73(7):438-42. PubMed ID: 20544592 [Abstract] [Full Text] [Related]
3. [Scope of the contract for drug therapy. Rebate contracts also for original drugs]. MMW Fortschr Med; 2009 Jul 23; 151(30-33):80. PubMed ID: 19722473 [No Abstract] [Full Text] [Related]
4. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany]. Pruszydlo MG, Quinzler R, Kaltschmidt J, Haefeli WE. Dtsch Med Wochenschr; 2008 Jul 23; 133(27):1423-8. PubMed ID: 18592450 [Abstract] [Full Text] [Related]
5. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness]. Leutgeb R, Mahler C, Laux G, Weschnetz A, Szecsenyi J. Dtsch Med Wochenschr; 2009 Jan 23; 134(5):181-6. PubMed ID: 19180404 [Abstract] [Full Text] [Related]
7. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices. Hoffmann F, Glaeske G, Pfannkuche MS. Dtsch Arztebl Int; 2009 Nov 23; 106(48):783-8. PubMed ID: 20038980 [Abstract] [Full Text] [Related]
8. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}]. MMW Fortschr Med; 2006 Feb 02; 148(5):45. PubMed ID: 16518939 [No Abstract] [Full Text] [Related]
9. [Limited prescribing freedom by federal cost regulation?]. Lasek R. Z Arztl Fortbild Qualitatssich; 1997 Nov 02; 91(7):633-5. PubMed ID: 9527458 [Abstract] [Full Text] [Related]
10. [Can physicians really save still more in drug prescriptions?]. Schmidt K. MMW Fortschr Med; 2006 Feb 02; 148(5):44-5. PubMed ID: 16518938 [No Abstract] [Full Text] [Related]
11. [Regress risk in aut idem prescribing]. Zimmermann GW. MMW Fortschr Med; 2014 Aug 21; 156(14):13. PubMed ID: 25195382 [No Abstract] [Full Text] [Related]
16. [Internists protest against drug regulation. The sanctioned physician--for the (lack of) welfare of the patient]. Thomas A. MMW Fortschr Med; 2006 Nov 02; 148(44):59. PubMed ID: 17619444 [No Abstract] [Full Text] [Related]
17. Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance. Weissenfeld J, Lüngen M, Stock S, Drabik A, Gerber A. Arzneimittelforschung; 2009 Nov 02; 59(9):476-81. PubMed ID: 19856796 [Abstract] [Full Text] [Related]
19. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report]. Fritze J. Nervenarzt; 2006 Mar 05; 77(3):376-83. PubMed ID: 17078120 [No Abstract] [Full Text] [Related]
20. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report]. Fritze J. Nervenarzt; 2008 Nov 05; 79(11):1337-45. PubMed ID: 19002733 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]